¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2024-07-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2024-07-06
±³À°ÀÏÀÚ : 2024-07-06
±³À°Àå¼Ò : SCÄÁº¥¼Ç¼¾ÅÍ, ¾Æ³ªÀ̽ºÈ¦

±³À°ÁÖÁ¦ : 2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå-Á¾¾çÇÐ ¿¬±¸È¸

´ã´çÀÚ : Â÷¿¬Á¤
¿¬¶ôó : 02-6002-1394

À̸ÞÀÏ : cardiooncology@naver.com

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 4 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í Àü¹®ÀÇ »çÀüµî·Ï-1¸¸¿ø, ÇöÀåµî·Ï-2¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 09:00~09:20 Cardiac biomarkers for initial screening of CTRCD: ÇÙ½É °á°ú °ª Çؼ®°ú À¯ÀÇÁ¡ ȲÈñÁ¤(°æÈñÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 09:20~09:40 Echocardiography for detection of CTRCD: ÇÙ½É °á°ú °ª Çؼ®°ú À¯ÀÇÁ¡ ÃÖ°­¿î(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 09:40~10:00 Medical treatment of CTRCD: How and how long? ¹ÚÇõÁø(Àü³²ÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 10:00~10:20 SGLT2 inhibitors: The emergence of a new rookie in the field of cardio-oncology Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë)

Åä·Ð 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 10:20~10:40 Discussion ±è´Ù·¡,±èÁöÇü,±èÀÎö,À̼ºÀ±,ÀÓ°æÈñ,±è±Ô,¹ÚÀαÙ,¹Ú¼¼ÈÆ,±è¹Î°æ,À±ÇöÁÖ(¼º±Õ°üÀÇ´ë,¿¬¼¼ÀÇ´ë,°è¸íÀÇ´ë,ÀÎÁ¦ÀÇ´ë,µ¿¾ÆÀÇ´ë,¿¬¼¼ÀÇ´ë,¿ï»êÀÇ´ë,¼º±Õ°üÀÇ´ë,¿µ³²ÀÇ´ë,Àü³²ÀÇ´ë)

ÈÞ½Ä 07¿ù 06ÀÏ 10:40~11:00 Coffee Break ()

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 11:00~11:20 [Keynote Lecture] Immune checkpoint inhibitor: Current uses and future directions ÀÌÀ±±Ô(°­ºÏ»ï¼ºº´¿ø)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 11:20~11:40 [Interactive consultation 1] ICI myocarditis and non-inflammatory LV dysfunction ±è¹Ì³ª(°í·ÁÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 11:40~12:00 [Interactive consultation 2] ACS and atherosclerosis during chemotherapy ¿À±Ôö(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 12:00~12:20 [ÇÙ½ÉÁ¤¸®] Interpretation of ECG in patients using ICI (Çʼö ½ÉÀüµµÇؼ® ¹× Up-to-date ¸ð´ÏÅ͸µ ¹æ¹ý ¼Ò°³) ±è´ëÈÆ(¿¬¼¼ÀÇ´ë)

Åä·Ð 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 12:20~12:30 Discussion ÀÌÁöÀº,ÃÖÇýÁø,¼ÕÀå¿ø,±èµµ¿µ,½É¼ºÈÆ,°û¹ÌÇâ,ÀÌ´©¸®,ÇöÁØÈ£,Á¤ÁöÀ±(°¡Å縯ÀÇ´ë,¿¬¼¼ÀÇ´ë,¿µ³²ÀÇ´ë,¾ÆÁÖÀÇ´ë,±¹¸³¾Ï¼¾ÅÍ,±¹¸³¾Ï¼¾ÅÍ,Àü³²ÀÇ´ë,¿ï»êÀÇ´ë,¿µ³²ÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 12:30~13:00 My journey to solve clinical unmet needs in cardiooncology À±È£Áß(°¡Å縯ÀÇ´ë)

½Ä»ç 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 13:00~14:00 Á¡½É½Ä»ç ¹× ÃÑȸ ()

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 14:00~14:20 °Ç°­º¸Çè ºòµ¥ÀÌÅÍ ¿¬±¸ ¹× Çؼ® ½Ã À¯ÀÇÁ¡ ¾çÇʼº(Â÷ÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 14:20~14:40 Korean Cardio-oncology Fact Sheet: ºòµ¥ÀÌÅÍ À§¿øȸ È°µ¿°ú ÁÖ¿ä °á°ú ¹ßÇ¥ Á¶Àͼº(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 14:40~15:00 °øÅë µ¥ÀÌÅÍ ¸ðµ¨°ú ºÐ»ê¿¬±¸¸Á, µ¥ÀÌÅÍ °áÇÕ¿¬±¸: Cardio-oncology- °Ç°­º¸Çè ºòµ¥ÀÌÅÍ ¿¬±¸¸¦ ³Ñ¾î¼­ À¯½ÂÂù(¿¬¼¼ÀÇ´ë)

Åä·Ð 07¿ù 06ÀÏ SC ÄÁº¥¼Ç ¾Æ³ªÀ̽ºÈ¦ 15:00~15:10 Discussion À̼±È­,Á¶ÀºÁ¤,À̼ºÀº,ÃÖÀÚ¿¬,À±Á¾Âù(°è¸íÀÇ´ë,Áß¾ÓÀÇ´ë,°¡Å縯ÀÇ´ë,°í·ÁÀÇ´ë,°¡Å縯ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇѽÉÀåÇÐȸ ½ÉÀåÁ¾¾çÇבּ¸È¸ ÇÏ°è ½ÉÆ÷Áö¿ò : 2024-07-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024 ´ëÇѺñ¸¸ÇÐȸ Obesity Summer Çмú´ëȸ : 2024-07-06
´ÙÀ½±Û ´ëÇѺҾÈÀÇÇÐȸ (¿Â¶óÀÎ) ½ºÆ®·¹½º°ü¸® ÇÁ·Î±×·¥ : 2024-07-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21166 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ±âº»±³À° : 2024-07-19 0 7 2024-07-01
21165 ¼­¿ï (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(ÀÇ·áÀÎ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2024-07-19 0 8 2024-07-01
21164 ÀüºÏ ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦299Â÷ ¿ù·ÊÁý´ãȸ : 2024-07-19 0 4 2024-07-01
21163 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-07-18 0 5 2024-07-01
21162 °æ±â ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-°æÀÎ(³²ºÎ) : 2024-07-16 0 6 2024-07-01
21161 ¼­¿ï 2024³â 1Â÷ °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ °¡Á¤ÀÇÇб³½Ç ¿¬¼ö°­Á : 2024-07-14 0 1 2024-07-01
21160 ¼­¿ï 2024 Á¦16ȸ ´ëÇѼºÇü¿Ü°úÇÐȸ ´«¼ºÇü¿¬±¸È¸ Çмú½ÉÆ÷Áö¾ö : 2024-07-14 0 4 2024-07-01
21159 ¼­¿ï Á¦11ȸ ´ëÇѺñ°úÇÐȸ ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-07-14 0 3 2024-07-01
21158 ¼­¿ï °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ 2024³â ⸳62ÁÖ³â±â³ä ½ÉÆ÷Áö¾ö : 2024-07-13 0 2 2024-07-01
21157 ¼­¿ï Á¦46ȸ Çѱ¹½ÉÃÊÀ½ÆÄÇÐȸ ¿öÅ©¼¥ : 2024-07-13 0 3 2024-07-01
21156 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø 24³â ´ëµ¿¸Æ ½ÉÆ÷Áö¿ò : 2024-07-13 0 2 2024-07-01
21155 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Á¦18Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2024-07-13 0 2 2024-07-01
21154 ¼­¿ï 2024 ¿¬¼¼ÀÇ´ë Á¤Çü¿Ü°úÇб³½Ç ½ÉÆ÷Áö¿ò : ÃÖÁ¾Çõ ±³¼ö Á¤³â±â³ä : 2024-07-13 0 4 2024-07-01
21153 ¼­¿ï ´ëÇÑ¿Ü»óÁßȯÀÚ¿Ü°úÇÐȸ Á¦50Â÷ Áý´ãȸ (Management of upper & lower GI bleeding) : 2024-07-13 0 4 2024-07-01
21152 ºÎ»ê ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ ¿µ³²Áöȸ ÇÏ°èÁý´ãȸ : 2024-07-11 0 2 2024-07-01
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷